How should cancer presenting as a malignant pleural effusion be managed?

British Journal of Cancer

Volumn 74, Issue 5, 1996, Pages 832-835

  Bonnefoi, H ^a   Smith, I E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Malignant pleural effusion; Unknown primary carcinoma

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; MITOMYCIN C; VINBLASTINE;

ADULT; AGED; ARTICLE; BRONCHOSCOPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; FIBEROSCOPE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CANCER; MALE; MAMMOGRAPHY; PLEURA EFFUSION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; ULTRASOUND;

EID: 0029740159     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.444     Document Type: Article

References (21)

1. ABBRUZZESE JL, ABBRUZZESE MC, HESS KR, RABER MN AND FROST P. (1994). Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J. Clin. Oncol., 12, 1272 1280.
2. EELIS PA, SMITH IE, HARDY JR, NICOLSON MC, TALBOT DC, ASHLEY SE AND PRIEST K. (1995). Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancer. Br. J. Cancer, 71, 366 370.
3. FEINSILVER SH, BARROWS AA AND BRAMAN SS. (1986). Fiberoptic bronchoscopy and pleural effusion of unknown origin. Chest, 90, 516-519.
4. FENTIMAN IS, MILLIS R, SEXTON S AND HAYWARD JL. (1981). Pleural effusion in breast cancer: a review of 105 cases. Cancer, 47, 2087-2092.
5. FENTIMAN IS, RUBENS RD AND HAYWARD JL. (1986). A comparison of intracavitary talc and tetracycline for the control of pleural effusions secondary to breast cancer. Eur. J. Cancer Clin. Oncol., 22, 1079-1081.
6. HAINSWORTH JD, JOHNSON DH AND GRECO FA. (1992). Cisplatin-based combination chemotherapy in the treatment of poorly differentiated carcinoma and poorly differentiated adenocarcinoma of unknown primary site: results of a 12-year experience. J. Clin. Oncol., 10, 912-922.
7. HAMED H, FENTIMAN IS, CHAUDARY MA AND RUBENS RD. (1989). Comparison of intracavitary bleomycin and talc for control of pleural effusions secondary to carcinoma of the breast. Br. J. Surg., 76, 1266-1267.
8. KIANG DT AND KENNEDY BJ. (1977). Estrogen receptor assay in the differential diagnosis of adenocarcinomas. JAMA, 238, 32-34.
9. LITTLE AG, FERGUSON MK, STASZEK VM AND SKINNER DB. (1988). Pleuro-peritoneal shunting. Alternative therapy for pleural effusions. Ann. Surg., 208, 443-450.
10. MASOOD S. (1992). Use of monoclonal antibody for assessment of estrogen and progesterone receptors in malignant effusions. Diag. Cytopathol., 8, 161-166.
11. MILLER AB, HOOGSTRATEN B, STAQUET M AND WINKLER A. (1981). Reporting results of cancer treatment. Cancer, 47, 207-214.
12. MOTTOLESE M, VENTURO I, DONNORSON RP, CURCIO CG, RINALDI M AND NATALI PG. (1988). Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin. Eur. J. Cancer Clin. Oncol., 24, 1277-1284.
13. NYSTROM JS, WEINER JM, WOLF RM, BATEMAN JR AND VIOLA MV. (1979). Identifying the primary site in metastatic cancer of unknown origin. JAMA, 241, 381-383.
14. RINGENBERG QS AND YARBRO JW. (1986). Presentations and clinical syndromes of tumors of unknown origin. In Clinical Oncology Monographs, Fer MF, Greco FA, Oldham RD (eds) pp. 101-120. Grune & Stratton: Orlando.
15. RUCKDESCHEL JC, MOORES D, LEE JY, EINHORN LH, MANDELBAUM I, KOELLER J, WEISS GR, LOSADA M AND KELLER JH. (1991). Intrapleural therapy for malignant pleural effusions: a randomized comparison of bleomycin and tetracycline. Chest, 100, 1528-1535.
16. SEARS D AND HAJDU SI. (1987). The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol., 31, 85-97.
17. STECKEL RJ AND KAGAN AR. (1980). Diagnostic persistence in working up metastatic cancer with an unknown primary site. Radiology, 134, 367-369.
18. STEWART JF, TATTERSALL MHN, WOODS RL AND FOX RM. (1979). Unknown primary adenocarcinoma: incidence of over-investigation and natural history. Br. Med. J., 1979, 1530-1533.
19. TSANG V, FERNANDO HC AND GOLDSTRAW P. (1990). Pleuroperitoneal shunt for recurrent malignant pleural effusions. Thorax, 15, 369-372.
20. WEBB WR, OZMEN V, MOULDER PV, SHABAHANG B AND BREAUX J. (1992). Iodized talc pleurodesis for the treatment of pleural effusions. J. Thorac. Cardiovasc. Surg., 103, 881-886.
21. WOODS RL, FOX RM, TATTERSALL MHN AND LEVI JA (1980). Metastatic adenocarcinomas of unknown primary site. N. Engl. J. Med., 303, 87-89.